4 unknown, 1 recruiting. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Unknown 4, Recruiting 1 |
| Phase 1 | 1 | Unknown 1 |
Follow SHR1701: new trials by email Literature Review of SHR1701 trials Research Report on SHR1701
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PDL1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer SHR1701, SHR2554, CAPOX - Advanced Gastric Cancer, SHR1701 | Phase 2 | Recruiting | The First Affiliated Hospital of Zhengzhou University | 78 | 2025-06-15 | 2026-09-01 |
| To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma SHR-1701, Temozolomide - Melanoma | Phase 2 | Unknown | Yong Chen | 31 | 2022-01-21 | 2023-06-07 |
| A Trial of SHR1701 Combined With Radiotherapy for Metastatic Non-small Cell Lung Cancer Failure After First-line Treatment SHR1701 - Non-Small-Cell Lung Cancer | Phase 2 | Unknown | Shandong Cancer Hospital and Institute | 15 | 2020-09-01 | 2020-09-23 |
| Phase Ⅰ/Ⅱ Study of SHR2554 in Combination With SHR1701 in Patients With Advanced Solid Tumors and B-cell Lymphomas SHR2554+SHR1701, SHR1701 - Solid Tumor, Lymphoma | Phase 1 / Phase 2 | Unknown | Chinese PLA General Hospital | 100 | 2020-09-01 | 2023-12-12 |
| Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer SHR7390, Famitinib, SHR3162 - Breast Cancer, Metastatic Cancer | Phase 2 | Unknown | Fudan University | 319 | 2020-05-01 | 2022-07-26 |
Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Lymphoma (1) · Melanoma (1) · Neoplasm Metastasis (1)
Chinese PLA General Hospital (1) · Fudan University (1) · Shandong Cancer Hospital and Institute (1) · The First Affiliated Hospital of Zhengzhou University (1) · Yong Chen (1)
China (4)
JinMing Yu, PhD (1) · Weidong Han, PhD (1) · Zhi-Ming Shao (1)